One of our lines of work involves the evaluation of neuroprotective molecules in cerebral ischemia, and after several in vitro and in vivo models we have seen protection in one of our compounds. Then we performed mitochondrial studies using mitochondria isolated from rat liver and found that our compound inhibited peroxide production, blocks the entry of calcium into the mitochondria and inhibits the ATP hydrolase. However, a referee at the

University disagrees with the results because we have used liver mitochondria to demonstrate neuroprotective effects. I've seen others working using the same liver mitochondria in order to demonstrate neuroprotective effects. I would be very grateful if any of you can help me to answer to the referee on this question and help me to justify it is valid using liver mitochondria in these neuroprotectives assays.

More Yanier Nuñez-Figueredo's questions See All
Similar questions and discussions